China Universal Asset Management Company’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $277K | Buy |
21,120
+2,127
| +11% | +$27.9K | 0.03% | 285 |
|
|
2025
Q1 | $418K | Sell |
18,993
-1,084
| -5% | -$23.8K | 0.04% | 261 |
|
|
2024
Q4 | $536K | Buy |
20,077
+2,042
| +11% | +$54.5K | 0.05% | 243 |
|
|
2024
Q3 | $481K | Buy |
18,035
+7,062
| +64% | +$188K | 0.05% | 224 |
|
|
2024
Q2 | $198K | Sell |
10,973
-6,908
| -39% | -$124K | 0.03% | 246 |
|
|
2024
Q1 | $326K | Buy |
17,881
+10,543
| +144% | +$192K | 0.04% | 230 |
|
|
2023
Q4 | $80.3K | Buy |
7,338
+5,704
| +349% | +$62.4K | 0.02% | 310 |
|
|
2023
Q3 | $9.36K | Buy |
1,634
+805
| +97% | +$4.61K | ﹤0.01% | 350 |
|
|
2023
Q2 | $6.43K | Sell |
829
-28
| -3% | -$217 | ﹤0.01% | 346 |
|
|
2023
Q1 | $5.72K | Buy |
857
+215
| +33% | +$1.43K | ﹤0.01% | 351 |
|
|
2022
Q4 | $5.74K | Buy |
642
+175
| +37% | +$1.56K | ﹤0.01% | 282 |
|
|
2022
Q3 | $5K | Buy |
+467
| New | +$5K | ﹤0.01% | 270 |
|